Julia Mirer, MD

Dr. Julia Mirer is an advisor and advocate in the emerging field of psychedelic medicine, serving as a bridge between eastern and western practices, committed to merging them to help create a new paradigm for integrative health and wellness. Her passion lies in education and advocacy for the responsible use of these medicines. Dr. Mirer believes that a successful future for this field depends on the interplay between policy, research, and clinics and has therefore positioned herself to play a role in each. Nationally, Dr. Mirer is an advisor for the Plant Medicine Coalition, lobbying the NIH for $100 million for psychedelic research. In Florida, she works in psychedelic clinical research at Segal Trials as a facilitator for USONA’s phase 2 trial using Psilocybin for Major Depression. Most recently, Dr. Mirer joined Nushama as Director of Strategy, where she hopes to combine all of her experience to realize the vision of a new type of healthcare system.